Telehealth company Hims & Hers Health (NYSE:HIMS) announced in Q4 CY2024, with sales up 95.1% year on year to $481.1 million.

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts’ expectations, but the stock sank in extended ...

Compounding pharmacy and IBD 50 newcomer Hims & Hers Health reported bullish earnings and sales growth late Monday. But Hims stock tanked. Please watch the video at Investors.com - The Weight-Loss ...

Revenue excluding its GLP-1 offering increased 43% to $1.2 billion in 2024 from a year earlier, said Chief Financial Officer Yemi Okupe. Including sales of its weight-loss treatments, revenue surged ...

In response, the White House-appointed Leland Dudek, who previously worked in the agency's anti-fraud office, as the new acting commissioner. President Donald Trump has nominated Fiserv FI -0.11% Get ...

Hims & Hers Health reports its fourth-quarter results after Monday's closing bell. Here's a look at the key figures from the ...

Bryant White confessed his inextinguishable flame for Desiree while toasting her nuptials to his ex-buddy. Bryant and Desiree are now happily married. Heather Lynn, an October 2022 bride from North ...

We recently compiled a list of the 12 Best Performing Small Cap Stocks So Far in 2025. In this article, we are going to take ...

"You can see her processing. So we just bounce around the yard happily all day, every day? That's my life now?!" one user commented.

For most German companies, removing the threat of a global trade war would be far more impactful than the local election result. Less than 20 per cent of revenue across the large-cap index is ...

On Friday, the Food and Drug Administration declared the semaglutide shortage over, sending Hims & Hers shares down 26%.